This is a guest post by Ray Miller and Megan E. Bowers, Ph.D. at DLA Piper. Ray may be contacted at [email protected]. When it comes to protecting therapeutic assets, I…
The post The value of method of use patent claims in protecting your the…
The value of method of use patent claims in protecting your therapeutic assets Read Post »
Drugs contain ingredients with therapeutic activity, so-called “active ingredients” as well as inactive ingredients. These inactive ingredients, called excipients, are included in oral products for various reasons, such as to…
The post 2 Strategies to …
2 Strategies to Grow Your Excipient Business by Tracking Drug Patents Read Post »
DrugPatentWatch developed this course to help users better understand the complexities and common strategies around brand erosion and generic entry. The positive responses received made it apparent that the course…
The post Free Online Course on Drug P…
Free Online Course on Drug Patents, Generic and Branded Drugs Read Post »
DrugPatentWatch has been ranked the “Best Biopharmaceuticals Commercial Business Intelligence Platform” by Global Health & Pharma News This award is dedicated to honoring the innovation, determination and outstanding levels of…
The post DrugPatentWatch…
DrugPatentWatch Ranked Best Biopharmaceuticals Commercial Business Intelligence Platform Read Post »
DrugPatentWatch’s Custom Market Surveillance provides you with a robust platform to monitor your business opportunities from every angle. You’re monitoring your business, but you’re too busy to sift through data.…
The post DrugPatentWatch Custom Market…
Before the passage of the Biologic Patent Transparency Act DrugPatentWatch’s biologic patent data was cited as a reason why the law should not be passed. Thankfully, the Act advanced, and…
The post Updating the DrugPatentWatch Biologics Module appeared…
This paper was originally published by Andreas H. Göller, Lara Kuhnke, Floriane Montanari, Anne Bonin, Sebastian Schneckener, Antoniuster Laak, Jörg Wichard, Mario Lobell, and Alexander Hillisch in Drug Discovery Today…
The post Bayer’s in silico ADMET…
This paper was originally published by Md. Imtiaz Hasan et al in Journal of Biosciences and Medicines under a Creative Commons Attribution 4.0 International License Abstract Development of generic drug product…
The post Development of Generic Drug Prod…
When it comes to pricing generic drugs, there are a number of factors that come into play. In countries without drug price regulations, the pricing is based largely on profitability.…
The post Strategies for Pricing Generic Drugs appeared first on Drug…
Want insights into the biggest revenue-changing events? ➤ Get Your Certificate Today By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay…
The post Get Your Certi…
Get Your Certificate in Generic and Branded Drug Lifecycle Management Read Post »